BALA CYNWYD, Pa., April 20, 2016 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Hansen Medical, Inc. ("Hansen Medical" or "the Company") (Nasdaq- HNSN-News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Auris Surgical Robotics, Inc. ("Auris").

Click here to learn more about the investigation http://brodsky-smith.com/1063-hnsn-hansen-medical-inc.html, or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, Hansen Medical shareholders will receive only $4.00 in cash for each share of Hansen Medical stock they own. The investigation concerns whether the Board of  Hansen Medical breached their fiduciary duties to shareholders and whether Auris is underpaying for the Company. The transaction may undervalue the Company and would result in a substantial loss for long term  Hansen Medical shareholders. For example, Hansen Medical stock traded at $23.30 per share on August 13, 2014 and traded at $8.40 per share on August 6, 2015.

If you own shares of Polycom and wish to discuss the legal ramifications of   the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA  19004, by visiting http://brodsky-smith.com/1063-hnsn-hansen-medical-inc.html, or calling toll  free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.


 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-brodsky---smith-llc-announces--investigation--of-the-board-of-directors-of-hansen-medical-inc--hnsn-300254985.html

SOURCE Brodsky & Smith, LLC

Copyright 2016 PR Newswire

Grafico Azioni Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di Hansen Medical, Inc. (MM)
Grafico Azioni Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di Hansen Medical, Inc. (MM)